account_id none on file
legal_name Akari Therapeutics Plc
ticker AKTX
cik 1541157
domain akaritx.com
linkedin_company_url https://www.linkedin.com/company/akaritx
entry_point_account_id none on file
name Akari Therapeutics plc
exchange Nasdaq
sector Health Care
hq Tampa, FL, United States
sector index/company/sector/health-care/
calls 0 filings 5 executives 0 family 0
why_nownone on file
callsnone on file
filings
Company currently leases office space for our U.S. headquarters on a short-term basis. The Company leases its U.S. headquarters virtual
filing / Aug 13, 2026 / receipt
Farag will serve as our Interim Chief Financial Officer, effective on October 22, 2025. The Farag Consulting Agreement provides for a monthly cash fee of $18,000 through the end of 2025 and a monthly cash fee of $27,000 starting January 1, 2026 through to February 15, 2026, pro-rated for any partial months.
filing / Jun 4, 2026 / receipt
Farag will serve as our Interim Chief Financial Officer, effective on October 22, 2025. See “Executive Compensation” in this Proxy Statement for more information.
filing / Jun 4, 2026 / receipt
a practice known as “householding.” This delivery method can result in meaningful cost savings for the Company. In order
filing / Jun 4, 2026 / receipt
leased office space for our former U.K. headquarters in London from The Doctors Laboratory (“TDL”), an entity with a common
filing / Jun 4, 2026 / receipt
executivesnone on file
familynone on file
upcoming
| 2026-11-12 | earnings call | scheduled | ir |
changes
| 2024-11-14 | director, departed | sec_8k |
| 2024-08-23 | President and Chief Executive Officer, departed | sec_8k |
| 2024-05-01 | President and Chief Executive Officer, departed | sec_8k |
mcp_package_hint
slug akari-therapeutics-plc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$